Skip to main content
. Author manuscript; available in PMC: 2011 Jun 6.
Published in final edited form as: Int J Dev Neurosci. 2004 Aug-Oct;22(5-6):321–328. doi: 10.1016/j.ijdevneu.2004.03.002

Table 2.

Receptor affinity, KD (pM) from oxytocin receptor saturation binding

Brain Area Treatment
F
Saline Cocaine Fluoxetine Amfonelic acid/fluoxetine
Amygdala 0.09 ± 0.01 0.11 ± 0.01† 0.13 ± 0.01*,† 0.07 ± 0.01 10.62
MPOA 0.14 ± 0.02 0.09 ± 0.01 0.11 ± 0.02 0.12 ± 0.01 2.66
Hippocampus 0.27 ± 0.01 0.13 ± 0.01* 0.15 ± 0.03 0.17 ± 0.05 4.61
VTA 0.09 ± 0.01 0.08 ± 0.01 0.05 ± 0.01 0.08 ± 0.01 3.73

Results are mean ± S.E.M. of three determinations for each treatment group.

*

P < 0.05 vs. saline.

†

P < 0.05 vs. amfonelic acid/fluoxetine.